SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-104439
Filing Date
2020-09-11
Accepted
2020-09-11 16:33:35
Documents
2
Period of Report
2020-09-09

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 7161
2 EX-24 ex-24.htm EX-24 8485
  Complete submission text file 0001104659-20-104439.txt   17038
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Ronsheim Matthew (Reporting) CIK: 0001824386 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38670 | Film No.: 201171339